Wellbutrin XL (bupropion hydrochloride) NDC 0187-0730

NDC codes

FDA NDC Directory

Product NDC (as listed)0187-0730Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00187-0730Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0187-0730-07	00187073007	7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-07)Marketed from Aug 29, 2003
0187-0730-30	00187073030	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-30)Marketed from Aug 29, 2003
0187-0730-90	00187073090	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-0730-90)Marketed from Aug 29, 2003

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Wellbutrin XLSuffix: XL
Generic name (nonproprietary): bupropion hydrochloride
Active ingredients: Bupropion hydrochloride — 150 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Bausch Health US LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021515
Marketing start: Aug 29, 2003
Listing expires: Dec 31, 2027
Other FDA classes: Dopamine Uptake Inhibitors (Mechanism)Increased Dopamine Activity (Physiologic effect)Increased Norepinephrine Activity (Physiologic effect)Norepinephrine Uptake Inhibitors (Mechanism)
Identifiers: Product ID 0187-0730_22308f71-fc56-430d-b559-bed47e17a46cSPL ID 22308f71-fc56-430d-b559-bed47e17a46cSPL set ID a435da9d-f6e8-4ddc-897d-8cd2bf777b21RxCUI 993541, 993545, 993557, 993564UNII ZG7E5POY8OUPC 0301870730302, 0301870731309
Pharmacologic class: Aminoketone

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400187073007 followed by a unit qualifier and the quantity

Package 00187-0730-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 10, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Wellbutrin XL is an aminoketone antidepressant, indicated for: • treatment of major depressive disorder (MDD) ( 1.1 ) • prevention of seasonal affective disorder (SAD) ( 1.2 ) 1.1 Major Depressive Disorder (MDD) Wellbutrin XL ® (bupropion hydrochloride extended-release) tablets is indicated for the treatment of major depressive disorder (MDD), as defined by the Diagnostic and Statistical Manual (DSM). The efficacy of the immediate-release formulation of bupropion was established in two 4-week controlled inpatient trials and one 6-week controlled outpatient trial of adult patients with MDD. The efficacy of the sustained-release formulation of bupropion in the maintenance treatment of MDD was …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021515

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021515
Product	Strength	Form · route	Labeler	Product NDC
Wellbutrin XLbupropion hydrochloride	Bupropion hydrochloride 300 mg/1	Tablet, Extended releaseOral	Bausch Health US LLC	0187-0731